Inhibitors of Proteinases as Potential Anti-Cancer Agents

Gluza, Karolina; Kafarski, Paweł

doi:10.5772/27713

Drug Development - A Case Study Based Insight Into Modern Strategies 2011

DOI: 10.5772/27713

|View full text |Cite

Inhibitors of Proteinases as Potential Anti-Cancer Agents

Karolina Gluza¹,

Paweł Kafarski²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 130 publications

(100 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Cloning and Characterization of Two Potent Kunitz Type Protease Inhibitors from Echinococcus granulosus

et al. 2015

View full text Add to dashboard Cite

The tapeworm Echinococcus granulosus is responsible for cystic echinococcosis (CE), a cosmopolitan disease which imposes a significant burden on the health and economy of affected communities. Little is known about the molecular mechanisms whereby E. granulosus is able to survive in the hostile mammalian host environment, avoiding attack by host enzymes and evading immune responses, but protease inhibitors released by the parasite are likely implicated. We identified two nucleotide sequences corresponding to secreted single domain Kunitz type protease inhibitors (EgKIs) in the E. granulosus genome, and their cDNAs were cloned, bacterially expressed and purified. EgKI-1 is highly expressed in the oncosphere (egg) stage and is a potent chymotrypsin and neutrophil elastase inhibitor that binds calcium and reduced neutrophil infiltration in a local inflammation model. EgKI-2 is highly expressed in adult worms and is a potent inhibitor of trypsin. As powerful inhibitors of mammalian intestinal proteases, the EgKIs may play a pivotal protective role in preventing proteolytic enzyme attack thereby ensuring survival of E. granulosus within its mammalian hosts. EgKI-1 may also be involved in the oncosphere in host immune evasion by inhibiting neutrophil elastase and cathepsin G once this stage is exposed to the mammalian blood system. In light of their key roles in protecting E. granulosus from host enzymatic attack, the EgKI proteins represent potential intervention targets to control CE. This is important as new public health measures against CE are required, given the inefficiencies of available drugs and the current difficulties in its treatment and control. In addition, being a small sized highly potent serine protease inhibitor, and an inhibitor of neutrophil chemotaxis, EgKI-1 may have clinical potential as a novel anti-inflammatory therapeutic.

show abstract

Cloning and Characterization of Two Potent Kunitz Type Protease Inhibitors from Echinococcus granulosus

et al. 2015

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Inhibitors of Proteinases as Potential Anti-Cancer Agents

Cited by 1 publication

References 130 publications

Cloning and Characterization of Two Potent Kunitz Type Protease Inhibitors from Echinococcus granulosus

Cloning and Characterization of Two Potent Kunitz Type Protease Inhibitors from Echinococcus granulosus

Contact Info

Product

Resources

About